Ehave (Ticker: EHVVF) is empowering the mental healthcare community with a next-generation of data-rich tools designed to improve patient management, diagnosis, and treatment. With Ehave Connect, Ehave’s mental health informatics platform, clinicians can make objective, data-driven decisions while keeping patients informed and engaged throughout their mental healthcare journey. Ehave Connect offers a powerful set of core features that integrate with a growing selection of tools and applications developed by Ehave and its leading partners, including Multi-Health Systems (“MHS”), a leading publisher of psychological assessments. Ehave is initially focused on improving the standard of care in attention deficit hyperactivity disorder (“ADHD”), through its collaboration with the Hospital for Sick Children (“SickKids”). Ehave Connect is also being utilized to advance the validation and optimization of medical cannabis, through its collaboration with MedReleaf. Ehave is headquartered in Toronto’s Discovery District, a hub of healthcare, innovation, and technology in Toronto, Canada.
EHAVE CONNECT: MENTAL HEALTH INFORMATICS PLATFORM
Ehave Connect is a mental health informatics platform that efficiently captures, integrates, and delivers high-quality, objective patient data. By bridging the substantial information gap in mental healthcare, while at the same time facilitating the deployment of novel digital assessment and remediation tools, we believe that we will empower clinicians and improve patient care.
Ehave is initially focused on developing solutions intended to improve the diagnosis and treatment of attention deficit hyperactivity disorder (“ADHD”). Ehave is also developing solutions for the medical cannabis industry.
An Evidence-Based Approach to Treatment Using Cannabis
The medical cannabis industry lacks comprehensive data for clinicians to draw from when advising patients on treatment plans, as well as reliable systems to track use and outcomes. Ehave is pioneering an evidence-based approach to treatment using cannabis, to improve the lives of patients and to support the emerging industry.
in partnership with
Improved Methods for Diagnosing and Treating ADHD
Attention deficit hyperactivity disorder (“ADHD”) is a common childhood disorder characterized by developmentally inappropriate levels of hyperactivity, impulsivity, and inattention. Despite extensive advances in understanding this complex disorder, improved methods for diagnosis and treatment are desired.
in partnership with